PMVP

PMV PHARMACEUTICALS INC

PMVP·69353Y103·US·Common Stock·Healthcare - Biotechnology-Activist

PMVP (PMV PHARMACEUTICALS INC) is held by 38 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($2.4M), TWO SIGMA INVESTMENTS, LP ($2.3M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($2.3M). Net institutional sentiment: Mixed.

38
Holders
Avg rating(6 Elite)
$13.4M
Total Value
53% (40)
Fund Consensus
17 buying - 15 selling
PMVPSmart Money Verdict
View all
Held by 38 funds
6 elite
Who's Trading
ActivistACArrowMark Colorado Holdings, LLC3.7%Jul 10, 2026
ActivistEUEuclidean Capital LLC4.9%May 15, 2026
ActivistSISio Capital Management, LLC5.8%May 4, 2026
ActivistOAORBIMED ADVISORS LLC0.0%Mar 4, 2026
ActivistACArrowMark Colorado Holdings, LLC5.8%Feb 17, 2026
ActivistBIBML Investment Partners, L.P.9.9%Feb 9, 2026
InsiderOLORBIMED ADVISORS LLCSell $1.5MOct 23, 2025
InsiderOLORBIMED ADVISORS LLCSell $900KSep 10, 2025
InsiderMHMack David HenrySell $62KJul 1, 2025
InsiderTRTicktin RobertSell $25KJul 1, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
2M$2.4M0.0%-23.46%
36
Increased
1.9M(+166.9%)$2.3M0.0%-25.37%
42
New
1.9M$2.3M0.0%-23.46%
36
Decreased
874,374(-20.1%)$1.1M0.0%-16.78%
0
Increased
864,311(+774.1%)$1.1M0.0%-21.80%
41
Increased
495,922(+11.2%)$615,4550.0%-94.35%
18
Decreased
434,093(-6.7%)$538,2760.0%-14.48%
0
Increased
360,786(+156.8%)$447,3750.0%-23.66%
39
Unchanged
335,694$416,2610.0%-20.97%
0
New
298,126$369,6760.0%-23.46%
33
Increased
240,531(+0.2%)$298,2580.0%-10.20%
16
Unchanged
183,178$227,1410.0%-53.02%
0
Decreased
179,873(-65.7%)$223,0430.0%-0.81%
0
Decreased
124,014(-75.1%)$153,7770.0%-11.19%
0
Decreased
115,422(-69.8%)$143,1230.0%-86.21%
0
Decreased
114,864(-9.6%)$142,4310.0%-15.09%
0
Decreased
68,292(-6.7%)$84,6820.0%-19.89%
0
Increased
61,174(+232.0%)$75,8560.0%-17.31%
34
Decreased
45,048(-62.0%)$55,8600.0%-13.52%
0
New
32,460$40,2500.0%-23.46%
28

Showing 1-20 of 40

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used